/Lists

Biotech Late Stage Investors & VC Firms

350 firms in this list, with a median first check of $1M. 61 of them lead rounds. Generated from verified public data and updated continuously.

Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
111 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
222 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$100K – $50M
157 people
Lightspeed Venture Partners
Menlo ParkSeed–Late Stage$1M – $5M
117 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
126 people
RA Capital
BostonSeed–Late Stage
278 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
185 people
General Atlantic
New YorkSeries B–Late Stage$10M – $1B
472 people
Bain Capital
BostonPre-Seed–Late Stage
290 people
Transpose Platform Management
San FranciscoPre-Seed–Late Stage
23 people
Menlo Ventures
San FranciscoPre-Seed–Late Stage$1M – $20M
55 people
Sands Capital Ventures
ArlingtonSeed–Late Stage$10M – $30M
187 people
OrbiMed
New YorkSeed–Late Stage$1M – $75M
93 people
Founders Fund
San FranciscoSeed–Late Stage$500K – $5M
33 people
B Capital Group
San FranciscoPre-Seed–Late Stage$10M – $50M
99 people
Venrock
Palo AltoSeed–Late Stage$500K – $10M
69 people
SV Health Investors
LondonSeed–Late Stage$1M – $20M
88 people
Saints Capital
DenverGrowth–Late Stage
22 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people
Sofinnova Partners
ParisSeed–Late Stage$540K – $27M
79 people
Deerfield Management Company
New YorkGrowth–Late Stage
97 people
Inveready Technology Investment Group
San SebastiánPre-Seed–Late Stage$108K – $21.6M
60 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
Foresite Capital
West HollywoodSeed–Late Stage
44 people

Frequently asked questions

Who are the top biotech late stage investors & vc firms?
Top biotech late stage investors & vc firms include Alumni Ventures, General Catalyst, Sequoia Capital, Lightspeed Venture Partners, GV (Google Ventures), RA Capital, Norwest Venture Partners, General Atlantic — 350 firms in total meet the criteria.
What is the typical first check among biotech late stage investors & vc firms?
The median first check among the 350 biotech late stage investors & vc firms tracked here is $1M.
How many biotech late stage investors & vc firms lead rounds?
61 of the 350 biotech late stage investors & vc firms tracked here lead investment rounds.

Related lists

Data sourced from public filings and firms' own websites — see our methodology.